One of the new methods used to remove contaminants from effluent is electrocoagulation method, which sometimes combined with other increase removal efficiency contaminants. To simultaneously nickel, cyanide, zinc, and copper, method photo-electrocoagulation was along an oxidizing agent, namely hydrogen peroxide (Hp). In addition, effects factors affecting were studied, including pH, electrode a...

Fermi National Accelerator Laboratory, P.O. Box 500, Batavia, Illinois 60510, USA Physics Department, University of Illinois at Chicago, Chicago, Illinois 60607-7059, USA CERN, CH–1211 Genève 23, Switzerland Antwerp University, B–2610 Wilrijk, Belgium Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA Instituto de F́ısica de Cantabria (CSIC-UC), E–39005 ...

abstract population increase, limitation of water resources, and increasing volume of municipal wastewater, has caused the necessity of wastewater reuse. application of wastewater on soils seems to be the most economical method of its disposal and by percolating wastewater through the soil, its chemical quality is improved. for this purpose, a greenhouse experiment was carried out with polyethy...

Water contamination has become a global challenge which must be tackled. This study examined the level of water in four locations at Ogbete area Enugu state. Carters street had highest pH 5.23 is below WHO standards limits for drinking water. The conductivities ranged from conductivity 1445 µs/cm, (8-10,000 µs/cm), TDS (1000 mg/l., TSS (WHO (500 mg/l). For alkalinity, were all (150 mg/l) standa...

Cathepsin S was detected in bovine kidney, spleen, lymph nodes and lung by immunochemical methods. The immunostaining of cathepsin S in kidney was concentrated to the cells of the proximal tubule, where the enzyme was present in cytoplasmic granules. The purification method for cathepsin S from bovine spleen involved (NH4)2SO4 fractionation, chromatography on CM-Sephadex C-50, gel filtration on...

Signal transduction inhibitor 571 (STI 571), a potent and selective inhibitor of the tyrosine kinase activity of BCR– ABL, is an important advance in the treatment of chronic myelogenous leukemia (CML) patients in the advanced phase of disease or those with chronic phase (CP) intolerant or resistant to interferon (IFN) therapy [1–3]. Given at the dose of 400–600 mg p.o. daily, STI 571 is genera...